Postscripts Rx
Conversations Beyond the Prescription. Where pharma, HCPs, life science and digital health solutions meets patients—after the script is written. Conversations on digital health, engagement, and real-world impacts that are re-writing the future of patient engagement.
Podcasting since 2025 • 38 episodes
Postscripts Rx
Latest Episodes
When MFN Pricing Meets Patient Power: How Digital Support Becomes the Moat
Prices are leveling, but the real story is where competitive edge is moving: from rebates and discounts to experience, trust, and the moments that keep a patient on therapy. We dig into the MFN pricing model and its ripple effects across U.S. p...
•
13:06
PBMs, Transparency, and the D2C Pivot
Prices that used to hide in the shadows are stepping into the light—and it’s changing how patients get their medicines. We dive deep into the PBM reckoning: why scrutiny is mounting, how California’s new law opens the books on rebates and reimb...
•
14:54
Inside Pfizer’s Bold Bet on Direct-to-Consumer Drug Sales—and What It Means for Access, Pricing, and Power
A pharmaceutical giant just pressed the D2C button—and the ripple effects could reset how Americans find, pay for, and receive their medications. We unpack Pfizer’s move to list discounted drugs on TrumpRX, why visible pricing matters to patien...
•
12:29
Why Pharma Is Investing Back in the U.S.—And What It Means for Your Medicine
Policy sparks the shift, but patients feel the impact—faster access, steadier supply, and smarter support. We dig into why major pharma players are pouring billions into U.S. manufacturing, how most favored nation pricing is reshaping reimburse...
•
5:45
Why Your Medicine May Soon Say "Made in America"
The pharmaceutical landscape is undergoing a seismic shift as the Trump administration drops a bombshell 100% tariff on imported branded and patented drugs, effective October 1st. This game-changing policy mandates that pharmaceutical companies...
•
13:36
